Page last updated: 2024-11-07

metaraminol and Arteriosclerosis

metaraminol has been researched along with Arteriosclerosis in 1 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boulard, G1
Nicod, J1
Oca, C1
Berty, A1
Ellie, J1
Deckmyn, MC1
Baudet, E1
Gillardeau, G1

Other Studies

1 other study available for metaraminol and Arteriosclerosis

ArticleYear
[Anesthesia for carotid surgery with clamping under residual carotid pressure control].
    Annales francaises d'anesthesie et de reanimation, 1982, Volume: 1, Issue:3

    Topics: Aged; Arteriosclerosis; Carotid Artery Diseases; Carotid Artery, Internal; Cerebrovascular Circulati

1982